PHOTO
Sharjah: Zulekha Hospital saved the life of an infant suffering from Esophageal Atresia (EA), a rare birth defect in which a baby is born without part of the esophagus (the tube that connects the mouth to the stomach). Instead of forming a tube between the mouth and the stomach, the esophagus grows in two separate segments that do not connect. A baby with this birth defect is unable to pass food from the mouth to the stomach, and sometimes faces difficulty in breathing.
Joud, born at Zulekha Hospital Sharjah was diagnosed with the condition soon after his birth. He experienced symptoms that included frothy white bubbles in his mouth, coughing when feeding, blue color of the skin, especially during feeding and breathing difficulty. Although EA can be life-threatening in its most severe forms and could cause long-term nutritional concerns, majority of the children fully recover if it is detected early. The best treatment for EA is usually a surgery to reconnect the two ends of the baby's esophagus.
Dr. Mazen Salowm, Specialist Paediatric Surgeon commented: “On an average, the condition affects 1 in 2000 to 4000 live births with slightly higher incidence in male than female. The right care and treatment of esophageal atresia is highly dependent on the surgical expertise and facilities available in the treating hospital. At Zulekha Hospital, a fully experienced dedicated team including nurses, surgeons, neonatologists and anesthetists worked relentlessly to provide the baby with the best medical care.”
Joud underwent an innovative procedure where Dr. Mazen Salowm performed The Foker technique which allows esophageal lengthening facilitating end to end anastomosis in long gap esophageal atresia. Thoracotomy was done on the third day of birth which gave the doctors access to the organs within the chest. Two small silicon tubes (0.5 cm) were fixed to each end of the esophagus and connected to a thread that extracted through the chest wall to apply daily external traction on both esophageal ends, trying to elongate the esophagus by growth stimulation.”
The infant was on ventilated care for six days followed by rethoracotomy on the sixth day to reconnect the esophagus.
The parents thanked the medical team profusely and added, “We are extremely thankful for the excellent support to us by the Zulekha medical team during Joud’s difficult situation. The moments were very tense for us and we were assured of the best care by the doctor.”
Joud abstained from any liquid intake for a week. Following which a Gastrografin Swallows test was performed and that highlighted the successful reconnection of the esophagus.
The infant gradually recovered and was discharged with his mother on oral feeding.
About Zulekha Healthcare Group www.zulekhahospitals.com
Zulekha Healthcare Group is a Superbrand and among the forerunners in UAE healthcare. Today the Zulekha Healthcare Group includes two multidisciplinary hospitals in Dubai and Sharjah, as well as four UAE medical centres and three pharmacies providing specialised treatments in over 30 disciplines. The group also has a multidisciplinary hospital in India - Alexis. Zulekha Hospital has received extensive recognition for its commitment towards quality care and sustainable business practices, and recently received the prestigious Dubai Quality Award for the second time in four years, underling a commitment to providing high quality healthcare to patients and society.
Media Contact:
Sameena Khanam - Senior Manager PR and Communication
Zulekha Hospitals +971 6 5069254
skhanam@zulekhahospitals.com
Zainab Chakkiwala- Marketing Co-ordinator
T: +971 6 5069328
zchakkiwala@zulekhahospitals.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
